Aclaris Therapeutics, Inc. · NASDAQ:ACRS
Rock Springs Capital Management LP's stake in Aclaris Therapeutics, Inc. fell to 4.70% (Schedule 13G/A)
Event Mar 31, 2025 · Filed May 15, 2025
Rock Springs Capital Management LP's stake in Aclaris Therapeutics, Inc. fell to 4.70%, 5,046,309 shares, as a passive investor on Mar 31, 2025. Filed May 15, 2025 (Schedule 13G/A).
- Stake
- 4.70%
- Shares
- 5,046,309
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Rock Springs Capital Management LP | 4.70% | 5,046,309 |
| Rock Springs Capital LLC | 4.70% | 5,046,309 |
| Rock Springs Capital Master Fund LP | 0% | 0 |
| Mark Bussard | 4.70% | 5,046,309 |
| Kris Jenner | 4.70% | 5,046,309 |
Source
Related
- Aclaris Therapeutics, Inc.
- Rock Springs Capital Management LP
- Aclaris Therapeutics, Inc. shareholders
- Schedule 13G · Frazier Life Sciences Public Fund, L.P. · Sep 21, 2026
- Schedule 13G/A · Ra Capital Management, L.P. · Aug 14, 2026
- Form 4 · Kolbeck Roland Wilhelm · Aug 4, 2026
- Form 4 · Schiff Andrew N · Jun 8, 2026
- Form 4 · Molineaux Christopher P. · Jun 8, 2026